StockDrifts LogoStockDrifts

Caregen 214370

Company
케어젠Caregen
Insiders
4
Buys
25
Total Value
₩6.3B ($4.4M)
Avg Return
+466.58%
Last Filing
2026-07-10

Caregen (214370) has 25 disclosed insider purchases and 1 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩6.3B ($4.4M) in reported transaction value. The earliest filing StockDrifts holds for Caregen is dated 2024-02-28; the most recent is 2026-07-10. Across these filings the average return since disclosure is +466.58%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-31BUYMarket Buy
정용지
Yongji Jeong
CEO3.0K₩55,600+0.0%₩148M ($103K)
2026-07-10BUYMarket Buy
정용지
Yongji Jeong
CEO10.0K₩61,100+1.0%₩563M ($391K)
2026-05-26BUYMarket Buy
정용지
Yongji Jeong
CEO2.2K₩90,500-1.2%₩201M ($140K)
2026-04-28BUYMarket Buy
정용지
Yongji Jeong
CEO1.9K₩107,000-0.9%₩202M ($140K)
2026-04-24BUYMarket Buy
정용지
Yongji Jeong
CEO3.0K₩104,400+0.0%₩310M ($216K)
2026-04-10BUYMarket Buy
김중현
Joonghyun Kim
Non-executive director and other audit committee member500₩85,600+12.3%₩43M ($30K)
2026-03-24BUY신규선임
이영승
Youngseung Lee
Outside director and1.3K₩105,000-8.5%₩134M ($93K)
2026-01-19BUY신규선임
이승민
Seungmin Lee
Managing Director200₩77,400+87.9%₩15M ($11K)
2025-05-14SELLMarket Sell
라희숙
Ra Hee-sook
vice president-30.1K₩32,750-344.0%₩986M ($685K)
2024-12-23BUYMarket Buy
정용지
Yongji Jeong
CEO15.1K₩27,700+424.9%₩419M ($291K)
2024-12-10BUYMarket Buy
라희숙
Ra Hee-sook
vice president956₩24,100+503.3%₩23M ($16K)
2024-12-10BUYMarket Buy
정용지
Yongji Jeong
CEO8.7K₩24,100+503.3%₩210M ($146K)
2024-12-09BUYMarket Buy
라희숙
Ra Hee-sook
vice president2.0K₩22,350+550.6%₩45M ($31K)
2024-12-06BUYMarket Buy
정용지
Yongji Jeong
CEO23.6K₩23,300+524.0%₩549M ($382K)
2024-12-04BUYMarket Buy
라희숙
Ra Hee-sook
vice president597₩24,500+493.5%₩15M ($10K)
2024-12-02BUYMarket Buy
라희숙
Ra Hee-sook
vice president1.5K₩23,900+508.4%₩36M ($25K)
2024-11-12BUYMarket Buy
정용지
Yongji Jeong
CEO11.8K₩18,280+695.4%₩215M ($150K)
2024-10-24BUYMarket Buy
정용지
Yongji Jeong
CEO12.1K₩16,690+771.2%₩202M ($140K)
2024-09-06BUYMarket Buy
정용지
Yongji Jeong
CEO10.3K₩15,850+817.4%₩163M ($113K)
2024-09-04BUYMarket Buy
정용지
Yongji Jeong
CEO10.0K₩16,890+760.9%₩169M ($117K)
2024-09-03BUYMarket Buy
정용지
Yongji Jeong
CEO6.8K₩18,000+707.8%₩123M ($86K)
2024-09-02BUYMarket Buy
정용지
Yongji Jeong
CEO8.3K₩17,010+754.8%₩141M ($98K)
2024-08-06BUYMarket Buy
라희숙
Ra Hee-sook
vice president15.0K₩16,880+761.4%₩253M ($176K)
2024-08-06BUYMarket Buy
정용지
Yongji Jeong
CEO49.9K₩16,880+761.4%₩842M ($585K)
2024-08-06BUYMarket Buy
김은미
Eunmi Kim
vice president2.0K₩16,880+761.4%₩34M ($23K)
2024-07-24BUYMarket Buy
정용지
Yongji Jeong
CEO10.0K₩24,000+505.8%₩240M ($167K)
2024-06-19BUYMarket Buy
정용지
Yongji Jeong
CEO10.2K₩22,950+533.5%₩234M ($163K)
2024-05-28BUYMarket Buy
김중현
Joonghyun Kim
Outside director and1.4K₩21,150+587.5%₩29M ($20K)
2024-03-29BUYMarket Buy
김중현
Joonghyun Kim
Outside director and1.3K₩22,800+537.7%₩30M ($21K)
2024-02-28SELL임원퇴임
허성욱
Seongwook Heo
Outside director and-730₩23,850-509.6%₩17M ($12K)

Frequently asked questions

Who has been buying Caregen stock?
4 distinct insiders have filed 25 disclosed insider purchases in Caregen (214370), most recently on 2026-07-10. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Caregen have?
Caregen has 25 buy-side and 1 sell-side disclosures on record, covering ₩6.3B ($4.4M) in total reported value, spanning 2024-02-28 to 2026-07-10.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.